Purchases and Sales Made in Q2 2022 in Brooklyn Immuno Therapeutics, Inc. (BTX)
This table provides information about the institutional ownership of Brooklyn Immuno Therapeutics, Inc. (BTX) during Q2 2022. The information is specifically focused on institutions that hold shares of Brooklyn ImmunoTherapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 25, 2022
Q2 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-118KClosed |
$56.5K - $239K
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-125K- 90.78% |
$60K - $254K
|
12.7K
$0
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-148K- 11.49% |
$71.1K - $301K
|
1.14M
$0
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-202K- 80.4% |
$96.8K - $409K
|
49.1K
$0
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-216K- 47.01% |
$104K - $439K
|
244K
$0
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-441K- 82.73% |
$212K - $895K
|
92K
$0
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-688K- 94.52% |
$330K - $1.4M
|
39.9K
$0
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-688K- 94.52% |
$330K - $1.4M
|
39.9K
$0
|
|
Aug 15, 2022
Q2 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-1.16M- 21.04% |
$556K - $2.35M
|
4.34M
$0
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.17M- 49.24% |
$564K - $2.38M
|
1.21M
$0
|